Cross-Talk between Signal Transducer and Activator of Transcription (Stat5) and Thyroid Hormone Receptor-ß 1 (TRß1) Signaling Pathways
H. Favre-Young,
F. Dif,
F. Roussille,
B. A. Demeneix,
P. A. Kelly,
M. Edery and
A. de Luze
INSERM Unité 344 (H.F.-Y., R.F., K.P., E.M.)
Endocrinologie Moléculaire Faculté de Médecine
Necker Paris cedex 15, France 75730
Laboratoire de
Physiologie Générale et Comparée (FY.H., D.F.,
B.D., L.A.) Muséum National dHistoire
Naturelle UMR 8572 CNRS Paris cedex 05, France 75231
 |
ABSTRACT
|
---|
PRL and T3 are involved in
antagonistic regulations during various developmental processes in
vertebrate species. We have studied cross-talk between transcription
factors activated by these signaling pathways, i.e. signal
transducer and activator of transcription 5 (Stat5) and thyroid hormone
receptor ß1 (TRß1). Liganded TRß1 in the presence of its
heterodimeric partner, retinoid X receptor
(RXR
),
inhibited the PRL-induced Stat5a- and
Stat5b-dependent reporter gene expression by up to 60%. This
T3-inhibitory effect studied on Stat5 activity
was partly reversed by overexpression of a TRß1 dominant negative
variant mutated within its nuclear localization signal (TR2A). We next
showed that TRß1 and TR2A in the presence of RXR
increased and
decreased, respectively, Stat5 localization into the nucleus regardless
of hormonal stimulation. Thus, our data suggest that TRß1 can be
associated with Stat5 in the cytoplasm and may be involved in Stat5
nuclear translocation. In PRL-treated cells overexpressing
TRß1/RXR
, both Stat5 and TRß1 were coimmunoprecipitated,
indicating physical association of the two transcription factors. In
these cells, addition of T3 with ovine (o)PRL
decreased the amounts of total and tyrosine-phosphorylated Stat5 in the
cytoplasm compared with oPRL-treated cells. In the nucleus, no clear
difference was observed on Stat5 DNA-binding after treatment with PRL
and T3 vs. PRL alone in TRß1/RXR
transfected cells. However, antibodies directed against TRß1 lowered
Stat5-DNA binding and addition of the deacetylase inhibitor
trichostatin A (TSA) relieved T3 inhibition on Stat5
transcriptional activity. Thus, we postulated that the negative
cross-talk between TR and Stat5 on target genes could involve histone
deacetylase recruitment by liganded TRß1.
 |
INTRODUCTION
|
---|
PRL plays a crucial role in several aspects of vertebrate
physiology. PRL effects are related to growth and reproduction (1). In
mammals, the effect of PRL on the mammary gland is well known, whereas
in lower vertebrates its role is mainly in osmoregulation and
metamorphosis (2). It is now well documented that the actions of PRL
are mediated through the intracellular Janus kinase 2 (Jak2)/signal
transducer and activator of transcription 5 (Stat5) signaling pathways
(3). For the Stats transcription factors family, it is their tyrosine
phosphorylation by Jak2 upon hormonal stimulation, which prompts Stat5
dimerization, nuclear import, DNA binding, and activation of target
gene. Steroid/thyroid hormones have been frequently implicated in
synergistic or antagonistic effects with both PRL and GH, the receptors
of which are closely related and share similar signal transduction
pathways (3, 5). In particular, thyroid hormone (TH) exerts antagonist
effects on PRL action notably in mammary gland development or amphibian
metamorphosis. Indeed, hyperthyroidism has been shown to suppress
PRL-mediated mammary growth in virgin rats (6, 7), associated with
increased lethality of the pups and absence of lactation after
gestational delivery (8, 9, 10, 11, 12). Conversely, in amphibians, high levels of
PRL have been shown to inhibit T3-induced
metamorphosis (4, 13).
THs are implicated in numerous processes such as growth, maturation,
development, and metabolism of most tissues in mammals (14, 15, 16).
Addition of T3 leads to the activation of their
nuclear receptors and modulation of target gene expression. Two main
loci encoding thyroid hormone receptor
(TR
) and ß (TRß)
isoforms exist, each isoform differing somewhat in structure (17).
Based on hormone binding assays, it has been proposed that TRs are
nuclear regardless of their ligand status (18). However, the precise
distribution and the functional role of TR isoforms are not yet
entirely understood. Indeed, different functional roles of TRß and
TR
were first shown on a rat TRH transcript in vitro
(19), then in vivo by somatic gene transfer (20). Such
findings were confirmed with studies in knockout mice, in which TRß
was shown to be dispensable for normal developmental expression of some
T3-dependent target gene (21, 22, 23). Like many
receptors belonging to the superfamily of steroid/thyroid nuclear
receptors, thyroid hormone receptors (TRs) bind to specific TH-DNA
responsive elements (TRE) upstream of target gene in heterodimeric
complex with the 9-cis retinoid acid receptor (RXR)
(24). Recently, a number of studies have shown a cross-talk between
Stat5a and b with nuclear steroid receptors (25), such as
glucocorticoid receptor (GR) (26, 27), estrogen receptor (ER) (27),
progesterone receptor (PR) (28), and peroxisome proliferator-activated
receptor
(PPAR
) (29). Unliganded PR or GR are essentially
cytoplasmic. Thus, the observation that progestin or dexamethasone
treatment induces Stat5 translocation into the nucleus, possibly
mediated by the physical association of these liganded nuclear
receptors with inactivated Stat5 (27, 28, 30), is most important.
Nuclear entry of steroid nuclear receptors appears to be mediated by
the interaction of nuclear localization signals (NLSs) within the
proteins and specific NLS-binding proteins in nuclear pores (31, 32, 33).
In contrast, no residue comprising a Stat NLS has been yet
demonstrated, but dimerization of Stat5 molecules upon PRL stimulation
has been postulated to unmask a NLS (34). Thus, the mechanisms
underlying nuclear entry of numerous proteins, such as Stats monomers
or homo- and heterodimers that are present in the cytoplasm, remain to
be clarified.
In the present study, we investigated a possible inhibitory involvement
of T3 in the oPRL-induced activation of a target
gene in the HEK293 cell line. We carried out transfections so as to
express elements of both the PRLR/Stat5a signaling pathway and the
TRß1/RXR
pathway. We show that in TRß1/RXR
-transfected cells
T3 markedly repressed oPRL-dependent Stat5a or
Stat5b-induced reporter gene expression under the control of a
lactogenic responsive element (LHRE) or the ß-casein promoter. We
also show that overexpression of TRß1/RXR
results in an increased
nuclear localization of Stat5a regardless of ligand stimulation.
Conversely, overexpression of a dominant negative TRß1 mutated in its
NLS decreases both Stat5a nuclear localization and
T3-dependent inhibitory effects on PRL-induced
transactivation of the LHRE-thymidine kinase (TK)-luciferase promoter.
We also show the ability of Stat5a to associate with TRß1 in
cytoplasmic extracts of oPRL and oPRL + T3
treated cells. Furthermore, in oPRL-treated cells, addition of
T3 reduces phosphorylated Stat5a in the cytosol.
In electrophoretic mobility shift assay (EMSA) studies, with LHRE
probe, no band was supershifted after addition of antibodies directed
against TRß1. However, TRß1 antibodies lowered Stat5a nuclear DNA
binding when TRß1/RXR
was overexpressed. Finally, we show that
addition of the histone deacetylase inhibitor trichostatin A (TSA)
relieved T3 inhibition on Stat5a transcriptional
activity. Thus, our data indicate that TRß1/RXR
modifies the
subcellular distribution of Stat5a in unstimulated as well as in
stimulated cells. The inhibitory effect of T3
could result from an heterocomplex formation between Stat5a and
recruitment by liganded TRß1 of a histone deacetylase within the
transcriptional machinery in PRL-stimulated cells.
 |
RESULTS
|
---|
T3 in the Presence of TRß1 Alone or in
Combination with RXR
Inhibits oPRL-Induced Transcriptional
Activity
We have previously reported that heterologous cell systems,
supplied with the gene encoding the PRLR and the ß-casein
promoter-luciferase construct, can be used to study PRL-induced
signaling and activation of transcription (35). In the present study,
HEK293 cells were cotransfected with expression vectors encoding the
PRLR, TRß1, and the LHRE-TK-luciferase reporter gene, with or without
RXR
. Without RXR
, ovine (o)PRL treatment caused a 10-fold
induction of luciferase expression from the LHRE (Fig. 1A
, lane 2) as compared with controls
(Fig. 1A
, lane 1). T3 alone had no effect on
luciferase expression compared with control. However, when
T3 was added with oPRL, it inhibited
LHRE-dependent luciferase expression, by up to 20%, as compared with
oPRL-treated cells.

View larger version (22K):
[in this window]
[in a new window]
|
Figure 1. T3 in the Presence of TRß1/RXR
Heterodimer Inhibits oPRL-Induced LHRE-TK-Luciferase Activity
A, Cells were transfected with TRß1, PRLR, LHRE-TK-luciferase, and
the ß-galactosidase expression vectors. As indicated, cells were
stimulated by oPRL (1 µg/ml), hGH (1 µg/ml), and/or T3
(10- 8 M) added during 1012 h in the
starvation medium (at 37 C). B, Cells were transfected with
TRß1/RXR , PRLR, LHRE-TK-luciferase, and ß-galactosidase. The
same hormonal treatment was applied as described above. C, Cells were
transfected with GHR, TRß1, LHRE-TK-luciferase, and ß-galactosidase
expression vectors and stimulated as described above. Cells were
treated as described previously. The relative light units were measured
and normalized for ß-galactosidase activity. Results are the
mean ± SE of three independent experiments, each
performed in duplicate.
|
|
The same experimental procedure performed with RXR
did not modify
the basal or the oPRL-stimulated LHRE-dependent luciferase expression
compared with controls (Fig. 1B
, lane 7). In contrast, addition of
T3 in TRß1/RXR
transfected cells resulted in
a higher level of inhibition (<60%) of oPRL-induced
LHRE-dependent luciferase expression (Fig. 1B
, lane 8). This
T3-induced inhibition of the PRL transduction
pathway was dose dependent in cells expressing either TRß1 alone or
TRß1/RXR
heterodimers. Optimal inhibition occurred at
10-8 M T3
(range from 10-12 M to
10- 6 M, data not shown). As shown
in Fig. 1C
, a similar T3 inhibitory
effect on Stat5-mediated LHRE-TK-luciferase activity was obtained
when cells were transfected with GHR following the same experimental
procedure.
We next examined whether this inhibitory effect of
T3 on LHRE-induced reporter gene activity was
specifically dependent on Stat5a or Stat5b (Fig. 2
, A and B). For comparison, we studied
the inhibitory effect of TRß1/RXR
on the wild-type ß-casein
promoter linked to luciferase reporter gene activity (Fig. 2B
). For
this purpose, the same experimental procedure in the presence of
TRß1/RXR
with PRLR was applied. As shown in Fig. 2
, A and B,
we obtained the same inhibitory effects after stimulation by oPRL +
T3 in cells transiently cotransfected with the
ß-casein promoter and Stat5a or Stat5b relative to those
expressing LHRE (Fig. 2B
). However, Stat5a and Stat5b differentially
potentiated LHRE and ß-casein promoter activities. As shown in Fig. 2
, comparison of Stat5a/Stat5b-mediated activation shows a more
efficient transactivation potency of Stat5a than Stat5b on both the
ß-casein promoter and the LHRE promoter. Thus, in our studies, Stat5a
seems to be the member of Stat family involved as well as in LHRE or
ß-casein promoter activities. Moreover, the higher sensitivity to
Stat5a-mediated transcriptional activity was more apparent using
LHRE-luciferase promoter than with the ß-casein promoter. Indeed,
similar induction by oPRL was observed in control and cells
overexpressing Stat5b with LHRE (Fig. 2A
), whereas oPRL was unable to
potentiate ß-casein promoter activity in control cells in the absence
of added Stat5a or Stat5b (Fig. 2B
).

View larger version (24K):
[in this window]
[in a new window]
|
Figure 2. T3 Inhibits oPRL-Induced
LHRE-TK-Luciferase and ß-Casein-Luciferase Activity in the Presence
of TRß1/RXR , Stat5a, or Stat5b
A, Cells were transfected with TRß1/RXR , PRLR, LHRE-TK-luciferase,
ß-galactosidase, and Stat5a or Stat5b. As indicated, hormonal
treatment was performed in panels A and B as described in Fig. 1 . B,
Cells were transfected with same plasmids as in panel A but with
ß-casein-TK-luciferase. Arbitrary units are calculated as a percent
toward activity in oPRL-treated cells (lane 11). Results are the
mean ± SE of three independent experiments, each
performed in duplicate.
|
|
Effect of a NLS-Mutated TRß1 (GFP-TR2A) on LHRE-Luciferase
Activity
To further examine the TRß1-dependent,
T3-induced inhibition of Stat5a
transcriptional activity, we used a dominant negative receptor with
alanine substitution of
Lys184-Arg185 on the NLS
present in TRß1 (D-domain) (36). Transient transfections were
performed using green fluorescent protein (GFP)-TRß1 or the
NLS-mutated GFP-TR2A (Fig. 3
). Luciferase
expression estimated after cotransfection of GFP-TRß1 with
RXR
, PRLR, and the LHRE-TK-luciferase in the presence of
T3, oPRL, and T3 + oPRL
showed similar fold-induction of luciferase activity, as previously
observed with the wild-type TRß1 (compare Fig. 3A
with Fig. 1B
).
However, transfection of the NLS-mutated GFP-TR2A sharply attenuated,
from 60% to 20%, the T3-inhibitory effect
on PRL-induced LHRE-TK-luciferase expression obtained with the
wild-type GFP-TRß1 (Fig. 3B
).

View larger version (14K):
[in this window]
[in a new window]
|
Figure 3. Effect of T3 on LHRE-TK-Luciferase
Activity in GFP-TRß1- and GFP-TR2A-Transfected Cells
Cells were transfected with PRLR, RXR , and GFP-TRß1 (A) or
GFP-TR2A (B). Cells were stimulated with T3, oPRL, or both
as described in Fig. 1 . The relative light units were measured and
normalized for ß-galactosidase activity. Results are the mean ±
SE of three independent experiments, each performed in
duplicate.
|
|
Effect of TRß1/RXR
on Stat5a DNA Binding
The direct or indirect interactions between Stat5a and
TRß1 were investigated using an electrophoretic mobility shift assay
(EMSA) for Stat5a/LHRE protein-protein-DNA complex. The consensus LHRE
DNA sequence from the ß-casein promoter gene was used in this
experience. The 24 mers oligonucleotide sequence comprised one copy of
the Stat5a response element (5'-TTTCTTGGAA-3').
Nuclear extracts used were from cells transfected with PRLR, Stat5a,
TRß1, and RXR
(Fig. 4
, A and C) or
with PRLR and Stat5a only (Fig. 4B
). Twenty four hours later the cells
were stimulated over a period of 30 min with different combinations of
T3 (10-8 M)
and/or oPRL (1 µg/ml). No Stat5a DNA binding was seen in the
absence of oPRL (with or without T3) (Fig. 4
, A
and B, lanes 110). When cells were stimulated with oPRL, a specific
association of Stat5a to its DNA binding site was identified (Fig. 4
, A
and B, lanes 1120). Specificity of Stat5a for its consensus sequence
was verified by competition with a 100-fold excess of unlabeled
oligonucleotides (Fig. 4
, A and B, lanes 12 and 17). Adding 1 µg of
mStat5a antibodies resulted in the appearance of a supershifted band
containing Stat5a bound to DNA (Fig. 4
, A and B, lanes 13 and 18). With
the LHRE probe, no supershifted or shifted material was apparent after
addition of human (h)TRß1 antibodies in extracts of control or
stimulated cells by T3 (Fig. 4
, A and B, lanes 4,
5, 9, and 10). This absence of shift seems to be in agreement with a
lack of an apparent canonical consensus TRE on LHRE. In nuclear
extracts from oPRL and oPRL + T3 treated cells,
addition of increasing amounts of hTRß1 antibodies repeatedly
diminished the intensity of the shifted band when TRß1 and RXR
were overexpressed. As illustrated in Fig. 4A
, quantification of the
shift showed a reduction of 12% and 30%, respectively, in
oPRL-treated cells (lanes 14 and 15) and in oPRL +
T3-treated cells (lanes 19 and 20). HumanTRß1
antibodies did not affect the shifted band when TRß1 and RXR
were
not overexpressed in cells (Fig. 4B
, lanes 14, 15, 19, and 20). Such
reduced binding of shifted materials (Fig. 4A
) in the presence of
TRß1/RXR
is not fully understood but might represent an unstable
low-affinity heterocomplex containing Stat5a, TRß1, and RXR
associated within the LHRE consensus sequence and/or loosening of
specific Stat5a-DNA binding. Similar results were obtained when cells
were transfected with Stat5b instead of Stat5a (data not shown).
Moreover, addition of TRß1/RXR
apparently also increased Stat5a
DNA binding as shown in our EMSA when nuclear extracts originated from
T3 + oPRL- or T3-treated
cells, in comparison to cells transfected without TRß1/RXR
(Fig. 4A
, lanes 11 and 16; compare with Fig. 4B
, lanes 11 and 16).

View larger version (35K):
[in this window]
[in a new window]
|
Figure 4. EMSA Analysis of Stat5a and TRß1 with LHRE Probe
or with TRE Probe
A, Cells were transfected with PRLR, Stat5a, and TRß1/RXR and
stimulated with oPRL (1 µg/ml) and/or T3
(10-8 M) for 30 min at 37 C. EMSA analysis was
performed with 8 µg of nuclear protein incubated with 40,000 cpm of
32P-LHRE-probe. Supershifts were obtained with 1 µg of
anti-mStat5a (polyclonal) or 14 µg of anti-hTRß1 (monoclonal)
antibodies. Competitions were performed with 100-fold excess of
unlabeled probe LHRE and films exposed 48 h at -80 C. B, Cells
were transfected with only Stat5a and PRLR under the same conditions
applied in panel A. Panels A and B were quantified with ImageQuant
logiciel, and measurement corresponds to intensity shift percentage
relative to lane 16. C, EMSA analysis was performed with 8 µg of
nuclear extracts from T3 - and T3 + PRL-treated
cells and incubated with 10,000 cpm of the 32P-TREpal
probe. Supershifts were estimated after addition of anti-hTRß1 (1
µg) or anti-mStat5a antibodies (1 µg). The competition with cold
oligonucleotides was performed as described in panel A.
|
|
The specificity of supershifted materials by hTRß1 antibodies was
confirmed using the same EMSA conditions as described above, with a
palindromic (IR0) TRE oligonucleotide probe
(5'-AGGCTCAGGTCATGACCTGAGCCC-3') (Fig. 4C
). TRß1, RXR
,
and Stat5a were overexpressed in 293 cells stimulated during 30
min with T3 and T3 + oPRL.
In both groups specific shifts were observed in nuclear cells
extracts (Fig. 4C
, lanes 18). In these two treatment conditions the
shifted material was supershifted in presence of hTRß1 antibodies
(Fig. 4C
, lanes 4 and 8). A marked inhibition of the shift and
supershift was apparent in nuclear extracts from oPRL +
T3 (Fig. 4C
, lanes 58) compared with
T3-treated cells (lanes 14). When mStat5a
antibodies were used, no supershifted materials could be seen
regardless of the hormonal status of nuclear extracts used (Fig. 4C
, lanes 3 and 7). For all combinations of treatment, the specificity of
the shifted bands was validated by addition of 100-fold excess of
unlabeled TRE (Fig. 4C
, lanes 2 and 6).
Effect of T3 and oPRL on Stat5a and TRß1
in Whole Cell Extracts
Using Western blotting analysis we next investigated the
interactions between Stat5a and TRß1 and their phosphorylation
status. In all the transfection studies shown in Fig. 5
, A and B, cells were cotransfected with
PRLR, Stat5a, RXR
, and TRß1. As shown in Fig. 5A
, the effects of
oPRL and T3 on Stat5a phosphorylation was
estimated after immunoprecipitation with anti-mStat5a or anti-hTRß1
antibodies and immunoblotted with antiphosphotyrosine antibodies.
Tyrosine phosphorylation of Stat5a was only apparent in cells
stimulated by oPRL (1 µg/ml) (Fig. 5A
, Stat5a arrowhead).
A lower level of activated Stat5a tyrosine phosphorylation was
shown in the cytosol of cells incubated simultaneously with both oPRL
and T3 (Fig. 5A
, Stat5a arrowhead;
compare lanes 5 and 7). When the same extracts were immunoprecipitated
by anti-hTRß1 antibodies and immunoblotted with antiphosphotyrosine
antibodies, phosphorylated TRß1 was apparent in all extracts,
regardless of treatment (Fig. 5A
, TRß1 arrowhead). To
further evaluate whether or not coexpressed TRß1 might complex with
Stat5a, the ability of TRß1 to coimmunoprecipitate with Stat5a was
tested in whole cell extracts after addition of monoclonal hTRß1
antibodies and immunoblotting with polyclonal mStat5a antibodies (Fig. 5B
). Comparisons were performed using the same extract
immunoprecipitated and probed with mStat5a antibodies. Western blot
analysis after single immunoprecipitation and immunoblotting with
mStat5a antibodies revealed one specific band of 92 kDa. In whole cell
extracts immunoprecipitated by hTRß1 antibodies and probed with
mStat5a antibodies, Stat5a occurred only in cells stimulated by
oPRL or oPRL + T3 (Fig. 5B
, Stat5a
arrowhead). No apparent association of TRß1 with Stat5a
could be identified in unstimulated cells (control) or in cells
incubated with T3 alone. This TRß1-Stat5a
association was also observed in cytoplasmic extracts but was
undetectable in the nucleus (data not shown). Expression of endogenous
Stat5a and Stat5b in untransfected 293 cells was estimated in whole
cell extracts immunoprecipitated and probed with mStat5a or mStat5b
antibodies. As shown in Fig. 5C
, we were not able to detect Stat5b,
whereas low levels of Stat5a are present.

View larger version (25K):
[in this window]
[in a new window]
|
Figure 5. Effects of oPRL and T3 on Stat5a
Phosphorylation and Association with TRß1 in Whole Cell Extracts
Immunoprecipitation was performed with 20 µl of protein-A Agarose and
polyclonal anti-mStat5a antibodies or 20 µl of protein G-plus Agarose
with monoclonal anti-hTRß1 antibodies. The whole cell extracts were
imunoprecipitated with anti-mStat5a or with anti-hTRß1 during 2
h and run on a 7.5% SDS-polyacrylamide gel. A, PVDF membranes were
incubated with monoclonal antiphosphotyrosine antibodies (Stat5a
arrowhead) or monoclonal anti-hTRß1 antibodies (TRß1
arrowhead). B, The same membrane was stripped and
immunoblotted with anti-mStat5a antibodies (Stat5a
arrowhead). C, Whole cell extracts from untransfected cells
were immunoprecipitated with a polyclonal anti-mStat5a or anti-mStat5b
and immunoblotted with the same antibody (Stat5a arrowhead)
as described above.
|
|
Effect of TRß1/RXR
on Stat5a Nuclear Translocation
We further evaluated whether or not TRß1/RXR
affects the
subcellular distribution and nuclear translocation of Stat5a. All
transient transfections performed with PRLR and Stat5a were
complemented with TRß1 and RXR
(+TR) or control plasmid
pcDNA3 (-TR). Western blots were performed on
cytosolic (Fig. 6A
) and nuclear extracts
(Fig. 6B
). Extracts were immunoprecipitated and immunoblotted with
anti-mStat5a antibodies. In the presence of TRß1/RXR
, decreased
Stat5a levels were apparent in all cytosolic extracts compared with
controls (Fig. 6A
). In the nucleus, overexpression of TRß1/RXR
induced an increased nuclear localization of Stat5a (Fig. 6B
). In each
group of transfected cells (+TR or -TR), hormonal treatments did not
apparently modify Stat5a expression in cytosolic (Fig. 6A
) or nuclear
extracts (Fig. 6B
).

View larger version (24K):
[in this window]
[in a new window]
|
Figure 6. Overexpression of TRß1/RXR Heterodimer Induces
Translocation of Stat5a in the Nucleus
A, Cells were transfected with PRLR and Stat5a and complemented with
pcDNA3 in groups (-TR, lanes 1, 3, 5, and 7) or complemented with
TRß1/RXR in groups (+TR, lanes 2, 4, 6, and 8) or with GFP-TR2A in
groups (+TR, lanes 14, panels C and D). Cells were stimulated as
previously described in Fig. 4 . Immunoprecipitations were performed
with a polyclonal anti-mStat5a antibodies on cytoplasmic extracts (A
and C, upper panel) or nuclear extracts (B and D,
lower panel) (as described in Fig. 5 ). After transfer the
blots were probed with an anti-mStat5a (A, B, C, and D, Stat5a
arrowhead) or an antiphosphotyrosine (A and B, pTyr
arrowhead).
|
|
The same blots were then probed with antiphosphotyrosine antibodies
(Fig. 6
, A and B). Phosphorylated Stat5a was observed only in cytosolic
and nuclear extracts from cells stimulated with oPRL or with oPRL +
T3 (Fig. 6A
, lanes 58). In oPRL-treated cells
overexpressing TRß1/RXR
, a decreased amount of phosphorylated
Stat5a was apparent in the cytoplasm compared with cells without
TRß1/RXR
(Fig. 6A
, lane 6 vs. lane 5, pTyr
arrowhead). We found an opposite effect in the nucleus (Fig. 6B
, lane 6 vs. lane 5, pTyr arrowhead). This
trend toward Stat5a diminution in the cytoplasm was further lowered in
the presence of T3 + oPRL in both groups of
transfected cells (Fig. 6
, A and B, lane 8 vs. 7, pTyr
arrowhead). In contrast, increased amounts of phosphorylated
Stat5a and Stat5a protein could be found in the corresponding nuclear
compartment, when cells were transfected with TRß1/RXR
and treated
by oPRL or T3 + oPRL (Fig. 6B
, lanes 6 and 8,
pTyr arrowhead) than in cells without TRß1/RXR
(Fig. 6B
, lanes 5 and 7, pTyr arrowhead) or cells unstimulated by
oPRL (lanes 14).
In order to ascertain how the NLS-mutated GFP-TR2A/RXR
partly
abrogated the T3-inhibitory effect on PRL-induced
LHRE-TK-luciferase expression, we evaluated its role on the subcellular
distribution of Stat5a (Fig. 6
, C and D). Cytoplasmic and nuclear
extracts were immunoprecipitated and immunoblotted with anti-mStat5a
antibodies. No modification in the amount of Stat5a in the cytosol was
evidenced when GFP-TR2A was overexpressed between the different types
of treatment (Fig. 6C
). Overexpression of GFP-TR2A/RXR
did not
induce nuclear localization of Stat5a in control or
T3-treated cells (Fig. 6C
). Thus, overexpression
of GFP-TR2A did not apparently affect the amount of Stat5a present in
cytosolic or nuclear extracts.
The Effects of Histone Acetylation on
T3-Mediated Transcriptional Repression
To assess whether or not histone deacetylase activity is involved
in the T3-mediated repression of Stat5a-dependent
transcription, we tested the ability of TSA, a potent inhibitor of
histone deacetylase, to affect Stat5a-induced promoter activity.
Hormonal treatments were simultaneously performed in 293 cells with or
without TSA. As shown in Fig. 7
, in the absence of TSA, T3 addition inhibited
PRL-induced LHRE activity by up to 40%. Addition of TSA (1000
nM) potentiated oPRL-induced LHRE promoter activity as
illustrated by the 10-fold increase in luciferase expression (Fig. 7A
).
At the dose of TSA used in our study, TSA had no significant effect on
promoter activity in the absence of oPRL. In contrast, a clear
dose-response effect on oPRL-induced LHRE-TK-luciferase expression was
obtained with increased amounts of TSA (50 to 1000 nM)
(data not shown). As shown in Fig. 7B
, T3-dependent repression was almost fully
abrogated in the presence of TSA. Thus, our results suggest that
recruitment of histone deacetylase activity by liganded TRß1 might be
part of its inhibitory effect on LHRE promoter activity.

View larger version (18K):
[in this window]
[in a new window]
|
Figure 7. Deacetylase Inhibitor TSA Reverses the
T3 Inhibitory Effect of TRß1/RXR on LHRE-TK-Luciferase
Activity
A, Cells were transfected with PRLR, RXR , and TRß1. As indicated,
cells were stimulated by oPRL (1 µg/ml) and/or T3
(10-8 M) and 1000 nM of
TSA added during 1012 h in the starvation medium (at 37 C). The
relative light units were measured and normalized for ß-galactosidase
activity. Results are the mean ± SE of three
independent experiments, each performed in duplicate. B, Inhibition
percentage in oPRL-treated cells was estimated as % of
T3-induced reduction of luciferase activity in presence or
absence of TSA.
|
|
 |
DISCUSSION
|
---|
The present study demonstrates novel functional interactions
between TRs and PRL-induced Stat5a transcriptional activity. In the
presence of its receptor TRß1 alone, and further with the
TRß1/RXR
heterodimer, T3 induces a clear
inhibition of PRL-induced transcription. This
T3-dependent TRß1 inhibition was apparent with
both Stat5a and Stat5b, using PRLR and GHR on a construct containing
six copies of LHRE. These observations could partially explain the
observation that high levels of TH have been shown to inhibit
PRL-induced mammary gland development and milk production in mammals
(6). In recent years, a number of nuclear steroid receptors have been
identified that are critical for the transcriptional responses
transduced by Stat5. It is well established that phosphorylation of
Stat5 plays a central role in stabilizing the processes of dimerization
and nuclear translocation upon activation of PRL-induced gene
expression (37). However, the mechanisms underlying the formation of an
active Stat dimer and its translocation to the nucleus have not been
fully elucidated. No NLSs have been yet identified on Stat molecules,
raising the question of how they are imported to the nucleus (38).
In our model, after immunoprecipitation and Western blotting with
Stat5a antibodies, we showed that TRß1/RXR
, respectively,
decreased Stat5a protein level in the cytosol and increased Stat5a
nuclear protein localization, suggesting their association during the
process of induced nuclear translocation. This process occurred even in
control cells without oPRL and T3 and in
T3-treated cells. However, we were not able to
show in either of these groups the occurrence of stable
association between Stat5a and TRß1 or Stat5 DNA binding on the LHRE.
Thus our data suggest that overexpression of TRß1/RXR
induced
protein-protein interaction with Stat5a and increased nuclear
translocation and sequestration of a subpopulation of nonactivated
Stat5 monomer before any treatments in our model, similar to the
model of GR/Stat5 interaction (27). Indeed, similar LHRE- driven
luciferase activity was seen in the presence or absence of
TRß1/RXR
in control or oPRL-treated cells (our unpublished
observations). Moreover, expression of RXR
in the absence of TRß1
did not induce inhibition of Stat5a transcriptional activity or changes
in nuclear translocation (data not shown). However, RXR
potentiated
TRß1 interaction with translocation of inactivated Stat5a into the
nucleus.
The nuclear localization of TRß1 in the absence of ligand remains
controversial (36). Recently, an equal distribution of TRß1 isoforms
between the nucleus and cytoplasm has been observed in the absence of
ligand (36, 39). Alanine substitution of
Lys184-Arg185
in the D-domain of the GFP-TR2A mutant, between the DNA and hormone
binding domain of TRß1, was shown to inhibit both its nuclear
translocation and T3-mediated transactivation
(36). Using this mutated construct of TRß1 in our study, a marked
attenuation of the T3-inhibitory effect on Stat5a
transduction pathways was observed. This loss of
T3 inhibition was associated in our Western
blotting studies with a lowered amount of Stat5a translocated or
sequestrated in the nucleus. These data suggest that nuclear
translocation and/or sequestration of latent Stat5a monomers,
regardless of the hormonal treatment, might be closely linked to
unliganded TRß1 subcellular distribution in our study.
Stat5a phosphorylation plays a critical role in Stat5a dimerization,
nuclear translocation, and DNA binding (3). We show that Stat5a and
TRß1 could be coimmunoprecipitated in whole cell extracts only when
Stat5a phosphorylation was induced by oPRL treatment. Furthermore,
expression of TRß1/RXR
in oPRL-treated cells was associated with
increased amount of phosphorylated Stat5a in the nuclear compartment as
evidenced in our Western blotting studies. Thus, oPRL-induced Stat5a
phosphorylation and dimerization in our study likely strengthened the
binding affinity involved in the physical interactions between Stat5a
and TRß1 molecules.
Several functional interactions involving Stat5a or Stat5b and nuclear
receptors from the steroid/thyroid receptor family members have been
published (25, 26, 27, 28, 29, 30). Among them, reports on GR and PR suggested that
those nuclear receptors and Stat might converge and physically interact
in the cytoplasm, thereby enhancing Stat5a entry into the nucleus (27, 28). Moreover, overexpression of GR enhanced Stat5 tyrosine
phosphorylation and DNA binding (27), an effect possibly related to the
predominantly cytoplasmic subcellular localization of GR (40).
Interestingly, when overexpressing the GR, Cella et al. (30)
found 1.5 times more GR or Stat5 present in the nucleus, respectively,
in cells stimulated by oPRL or dexamethasone compared with unstimulated
cells, suggesting that inactive partner recruitment occurred before
nuclear translocation. Similar results were obtained with the PR (28).
Progesterone alone in the T47Dco breast cancer cell line also induced
nuclear translocation of Stat5, suggesting that liganded PR, like GR,
may be implicated as cotransporter of Stat5 in the nucleus.
Although increased phosphorylated Stat5a was present in the nucleus of
oPRL cells transfected with TRß1/RXR
, we were unable to detect,
with EMSA analysis and specific antibodies against TRß1, any
supershifted molecular complex representing a stable association of
Stat5a with TRß1. Nevertheless, addition of increased amounts of
TRß1 antibodies disrupted the shifted DNA binding of Stat5a from oPRL
and T3 + oPRL nuclear extracts when TRß1/RXR
were overexpressed but not in their absence. This latter observation
clearly supports the recruitment of TRß1 by activated Stat5a dimer
within its cognate DNA binding site. However, our data differ somewhat
from those obtained on the cross-talk between ER and Stat5.
Overexpression of ER in the presence of oPRL and estrogen was
associated with a clear inhibition of Stat5-DNA binding (27). In these
studies, the inhibitory effect of ER on Stat5 DNA binding was shown to
arise from a decreased Stat5a phosphorylation. Our data also differ
from the interactions between Stat5a and b with GR, which are among the
best studied compared with other members of this nuclear receptor
superfamily (26, 27, 30, 41, 42). GR does not bind to, but directly
associates with, Stat5 on its DNA response element (LHRE) in the
promoter of the ß-casein gene. Treatment with oPRL and dexamethasone
induced the formation of a GR/Stat5/DNA complex as confirmed in EMSA
where supershifted materials were seen using specific antiserum against
either Stat5 or the GR (26). Thus, the hypothesis we put forward to
explain such discrepancies in the literature is that the complex
containing Stat5a and TRß1 or Stat5 and ER on a Stat5 responsive
element (LHRE) possibly interacts with a lower or a weaker DNA binding
affinity compared with the heterocomplex containing GR and Stat5a. It
is important to mention that among members of the nuclear
steroid/thyroid receptor family, GR and PR differ from thyroid and ERs
in their recognition of DNA response elements (24, 43, 44). Several
half-GREs have been mapped in the ß-casein promoter (45), but no
half-site TRE that binds TR and ER (AGGTCA) has been reported.
Interestingly, PRs and GRs potentiated (25), whereas ER repressed (25),
Stat5 transcriptional activity as TRß1. However, we do not
fully understand how T3 or estrogen negatively
coordinates Stat5 DNA binding and gene transcription through its
responsive element. However, the data presented here are consistent
with the hypothesis that TRß1/RXR
and T3 in
the presence of PRL enhance dimerization of Stat5a in a functional
antagonistic heterocomplex with TRß1, thus increasing nuclear
translocation and DNA binding activity of this complex at the LHRE site
present in the promoter of the ß-casein gene. Such increased
DNA-binding activity of Stat5a dimer, as a result of increased
Stat5a/TRß1/RXR
nuclear translocation and/or its decreased nuclear
turnover, might represent one of the functional consequences in
TRß1/RXR
-mediated inhibition at the promoter level. A similar
model was demonstrated with GR and Stat5, PRL-induced Stat5
dimerization resulting in an increased nuclear localization of
unliganded cytoplasmic GR (27). Furthermore, physical interactions
between TRß1 and Stat5a might be only one component, the
transcriptional antagonism exhibited by this complex likely involving
recruitment of other partners to be operable on PRL-dependent target
genes. The experiments presented here strongly suggest the occurrence
of protein/protein interactions between Stat5a and TRß1 and the
transcriptional machinery in oPRL- and oPRL + T3
-stimulated cells. Consequently, the carboxy-terminal ligand binding
domain of TRß1 was likely not involved in this association, since a
clear inhibition of oPRL transcriptional activity could be obtained
only upon addition of T3.
In our EMSA analysis using an idealized TREpal we repeatedly observed
DNA binding of TRß1 supershifted by hTRß1 antibodies, in nuclear
extracts from T3- and T3 +
oPRL-treated cells. Additionally, a clear inhibition of the shifted and
supershifted TRE probe was seen in oPRL and oPRL +
T3 nuclear extracts compared with those
originating from T3-treated cells. This
observation seems relevant since GH significantly inhibited a
T3-induced TRE-CAT transcriptional activity when
TRß1 was overexpressed (46). Thus, it appears likely that the
physical cross-talk of TRß1 and Stat5a in our studies also affects
thyroid hormone transduction pathway. Such cross-talk observed only
during hormonal treatment might be stabilized by multiprotein complex
components in the transcriptional machinery such as nuclear corepressor
(NcoR) and SMRT (silencing mediator of retinoid and thyroid hormone
receptor) with associated HDACs or sin3 and Rpd3 histone deacetylase
activity or nuclear coactivator (NCoA) with histone acetyltransferase
activity (47). Members of the Stats family have been shown to interact
directly with the related coactivator p300 or with N-myc interactor
(Nmi), a new auxiliary protein downstream of CREB binding protein
(CBP)/p300 (48). CBP/p300 or the steroid receptor coactivator SRC-1
does not appear to participate in the Stat5a-mediated suppression of
the inhibitory effect of Stat5a on glucocorticoid or PPAR
responsive
elements (41, 46). However, we found in our present study that TSA,
a potent deacetylase inhibitor, potentiated PRL-induced gene
transcription and abrogated T3 inhibition on
Stat5a transcriptional activity. TSA markedly stimulated PRL
transduction pathway, suggesting that interplay between NCoA and NCoR
both occurred in Stat5a transactivation. TRH and TSH both have a
negative responsive element (nTRE) allowing negative feedback
regulation by TRß1 in the presence of T3 (19, 20, 49). Characterization of nTRE consensus nucleotide sequences
differs in TSH and TRH promoter (49, 50). Depending on the nTRE present
at the promoter level, unliganded or liganded TRß1/RXR
exerted its
negative regulation by recruitment of histone deacetylase. Thus, in
our model, liganded TRß1 could allow the recruitment of a complex
that contains histone deacetylase activity in its inhibitory effects on
Stat5a transcription activity as already postulated in the negative
feedback regulation of TSH (49).
Finally, the present data support the concept that those nuclear
receptors affecting Stat5 signaling have two key characteristics: they
all contain putative NLSs and all interact with the transcriptional
machinery either directly or indirectly (38). We postulate that the
interactions between Stat5a and TRß1 described in the present study
may be part of the mechanisms implicated in the TH-induced inhibition
of mammary gland development. Similar antagonistic cross-talk, but on a
T3 responsive element, might be also part of the
antagonistic effect elicited by PRL during TH-induced metamorphosis
in amphibians (13).
 |
MATERIALS AND METHODS
|
---|
Plasmids
As previously described (51), the LHRE-TK-luciferase construct
is a fusion gene carrying six copies of the LHRE DNA element present on
the ß-casein gene promoter upstream of the TK minimal promoter and
the coding region of the luciferase reporter gene. The wild-type
ß-casein-luciferase plasmid was a gift from Dr. Goffin (Paris,
France). The construct contains a fragment of the proximal promoter of
rat ß-casein extending from -2300/+490 inserted into NheI
site of luciferase reporter plasmid pGL2-E (51). Cytomegalovirus-based
expression plasmids were used for the pR/CMV vector
(Invitrogen, San Diego, CA) containing cDNAs encoding the
long form of the rat PRLR (35) and the pcDNA3-monkey (mk)-GHR (53).
Expression plasmid DNA, pXM-MGF/Stat5a, encoding bovine MGF/Stat5a, was
obtained from Dr. B. Groner (Freiburg, Germany). GFP-Stat5b expression
plasmid was introduced in a PEGFP-CI vector with a cytomegalovirus
(CMV) promoter kindly provided by Dr. J. Herrington (University of
Michigan, Ann Arbor, MI) (54). The human plasmid pSG5-TRß1 was
provided by Pr D. Stehelin (Lille, France). It was generated by
subcloning the 1.7-kb EcoRI fragment of TRß1 which
contains the cDNA for human erb-A into the pSG5 (55). The expression
vector pCMX-RXR
was provided by D. Mangelsdorf (Dallas, TX).
PCI-nGFP-TRß1 and the NLS-mutated construct pCI-nGFP-TR2A were
provided by Dr. S.-Y. Cheng (36) (NIH, Baltimore, MD). CMV
ß-galactosidase cDNA was used as internal control to normalize
LHRE-luciferase and ß-casein-luciferase expression in cell-transient
transfection assays (52), and pcDNA3 vector (Promega Corp., Madison, WI) was used for DNA complementation. Ovine PRL
(NIDDK-oPRL-20) was a gift from the National Hormone and
Pituitary/NIDDK program (Baltimore, MD), T3 was
purchased from Sigma (St. Louis, MO), and TSA was
purchased from Wako Pure Chemical Industries Ltd.
(Richmond, VA). Monoclonal anti-hTRß1 (sc-737 or sc-737X for EMSA),
polyclonal anti-mStat5a (sc-1081 or sc-1081X for EMSA), and polyclonal
anti-mStat5b (sc-835-G or sc-835X for EMSA) used for Western blot were
purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz,
CA). We used also a monoclonal antiphosphotyrosine (4G10; Upstate Biotechnology, Inc., Lake Placid, NY). Protein levels were
determined using Bio-Rad protein assay reagent (Bio-Rad Laboratories, Inc. Hercules, CA) (56).
Cell Culture and Transfections
The human embryonic kidney fibroblast HEK 293 cell line was used
for transient transfection and maintained in DMEMnut
F12 complemented with 10% FCS, 2 mM glutamine, and
antibiotics. Cells were split into six-well plates at a density of
800.000 cells per well (
70% confluency) in DMEM (4.5 g/liter of
glucose, 10% FCS, 2 mM glutamine, antibiotics) before
being transiently transfected using the calcium phosphate technique
(57) with 0.1 µg/well of LHRE-TK-luciferase and ß-galactosidase,
0.05 µg/well of PRLR, TRß1 (GFP-TRß1 or GFP-TR2A), and RXR
.
Within 15 h after transfection, the cells were starved in the
absence of FCS in DMEM (4.5 g/liter of glucose) for an additional
7 h of starvation. Cells were then stimulated during 1012 h for
functional test by oPRL (1 µg/ml), T3
(10-8 M), or TSA (1000
nM) added alone or in combination to culture medium.
Luciferase activity was measured in relative light units (RLU) and
normalized by the estimated ß-galactosidase activity, as previously
described (52).
Cytosolic and Nuclear Cell Extracts Preparation
HEK293 cells were grown in 100-mm culture dish. Transient
transfection was performed as above using 1 µg of cDNA encoding the
PRLR, Stat5a, TRß1, and RXR
. After transfection cells were treated
during 30 min with oPRL (1 µg/ml) and with T3
(10-8 M). Cells were subsequently
lysed with 1 ml of lysis buffer (10 mM Tris-HCL, pH 7.5, 5
mM EDTA, 150 mM NaCl, 30 mM sodium
pyrophosphate, 50 mM NaF, 1 mM
Na3VO4, 10% glycerol, 0.5% Triton X-100)
containing a cocktail of protease inhibitors (1 mM
phenylmethylsulfonyl fluoride (PMSF), 1 µg/ml pepstatin, 2 µg/ml
leupeptin, 5 µg/ml aprotinin) for 30 min at 4 C. All extracts were
aliquoted and frozen at -80 C.
Cells were washed with 1x PBS to remove media and serum, scraped, and
collected in 1 ml of 1x PBS with 1 mM of
Na3VO4. Cells were pelleted and resuspended by
repeated pipetting in 4 volumes of hypotonic buffer (10 mM
HEPES-KOH, pH 7.9, 1.5 mM MgCl2, 10
mM KCl, 0.5 mM dithiothreitol) supplemented
with 1 mM Na3VO4, 20 mM
NaF, and 0.2 mM PMSF. The cytoplasmic supernatant was
collected and nuclear pellet was resuspended in 1 volume of hypertonic
buffer on ice 1015 min (20 mM HEPES-KOH at pH 7.9, 1.5
mM MgCl2, 25% glycerol, 420
mM NaCl, 0.2 mM EDTA) and complemented with 0.2
mM PMSF, 0.2 mM phosphatase, 20 mM
NaF, and 1 mM Na3VO4. Extracts were
centrifuged at 10.000 rpm at 4 C for 10 min to remove nuclear debris.
All extracts were aliquoted and frozen at -80 C. Each aliquot was
thawed only once.
Immunoprecipitation and Western Blotting
For immunoprecipitation, 500 µl of lysates were incubated with
2 µl of anti-mStat5a antibodies (0.8 µg/ml) and anti-hTRß1 (1.2
µg/ml) and mixed with 30 µl of Protein A-Agarose or Protein G-plus
(Santa Cruz Biotechnology, Inc., TEBU) for 2 h
with shaking. The immunoprecipitate was collected by
centrifugation, washed in lysis buffer, and boiled for 5 min in
sample buffer (125 mM Tris, pH 6.8, 5% SDS, 10%
ß-mercaptoethanol, 20% glycerol). Immunoprecipitated proteins
were separated by SDS-PAGE (7.5%) for 2 h at 30 mA. The gel was
transferred onto polyvinylidene difluoride (PVDF) transfer membrane
(Polyscreen, NEN Life Science Products, Boston,
MA), and probed with anti-mStat5a or anti-mStat5b (Upstate Biotechnology, Inc., 1:1000), anti-hTRß1 (Upstate Biotechnology, Inc., 1:1000), antiphosphotyrosine
(Upstate Biotechnology, Inc., 1:10000) conjugated with an
antimouse or an antirabbit IgG-horseradish-peroxidase (1:5000)
and visualized by the ECL detection system (Amersham Pharmacia Biotech, Arlington Heights, IL) for 30 min at room
temperature.
Electrophoretic Gel Mobility Shift Assay (EMSA)
The same experimental procedure was used for cell culture
as described above. The single-strand sequences of LHRE used in our
assay were, respectively: 5'-AGGCTGACTTCTTGGAATTAGCCC-3'(sense),
5'-GGGCTAATTCCAAGAAGTCAGCCT-3'(antisense). These probes were provided
by Genaxis (Saint-Cloud, France). The palindromic TREpal was used for
TRß1 DNA-binding. This sequence contain a TRE underlined as follow:
5'-AGGCTCAGGTCA TGACCTGAGCCC-3' (sense) and
5'-GGGCTCAGGTCATG ACCTGAGCCT-3' (antisense).
The two complementary strands were annealed and end-labeled with
[32P]-dATP
by the Polynucleotide Kinase T4
and purified by P-6 Micro Bio spin columns (Bio-Rad Laboratories, Inc.). Eight micrograms of nuclear extracts were used per
reaction, 2 µg of poly(dI)-poly(dC) (Pharmacia Biotech,
Piscataway, NJ) were added to 2 µl of migration buffer
(50 mM Tris-HCl, pH 7.9, 12.5 mM
MgCl2, 1 mM EDTA, 1 mM
dithiothreitol, and 20% glycerol), and total volume was adjusted at 20
µl. The sample were incubated 30 min at 4 C with 40,000 cpm of probe.
When competitor was added to specific concentration as indicated, they
were included with extracts during the incubation of labeled probe. For
all antibodies, 1 µg to 4 µg/reaction were used and incubated 30
min before the reaction binding. Reactions were resolved on 4%
polyacrylamide (38:2 acrylamide/bis-acrylamide, Interchim) gels
containing 0.25x TBE. Gels were pre-run at 50 V overnight and run 1 to
1.30 h at room temperature. They were dried on wathman and
analyzed with Kodak (Eastman Kodak,
Rochester, NY) film after 48 h exposure at -80 C. We used the
ImageQuant logiciel (Molecular Dynamics, Inc., Sunnyvale,
CA) for calculating the percentage of shift intensity.
 |
ACKNOWLEDGMENTS
|
---|
The authors wish to thank the National Institute of Diabetes,
Digestive and Kidney Diseases, NIH (Bethesda, MD), Drs. A. Begue,
R. M. Evans, S.-Y. Cheng, C. Carter-Su, and L. Sachs for helpful
discussion and for their kind gifts of DNA and reagents.
 |
FOOTNOTES
|
---|
Address requests for reprints to: Dr. M. Edery, INSERM Unité 344, Faculté de Médecine Necker, 156 rue de Vaugirard, 75730 Paris cedex 15-France.
Received for publication August 18, 1999.
Revision received May 31, 2000.
Accepted for publication June 1, 2000.
 |
REFERENCES
|
---|
-
de Vlaming VL 1979 Actions of prolactin among the
vertebrates. In: Barrington EJW (ed) Hormones and Evolution. Academic
Press, New York, vol 2:561642
-
Nicoll CS 1974 Physiological action of prolactin. In: Knobil
E, Sawyer WH (eds) Handbook of Physiology, section 7, part 2. American
Physiological Society, Washington DC, vol 4:253292
-
Bole-Feyssot C, Goffin V, Edery M, Binart N, Kelly P 1998 Prolactin (PRL) and its receptor: actions, signal transduction pathways
and phenotypes in PRL receptor knockout mice. Endocr Rev 19:225268[Abstract/Free Full Text]
-
Clarke WC, Bern HA 1980 Comparative endocrinology of
prolactin. In: Li CH (ed) Hormonal Proteins and Peptides. Academic
Press, New York, vol 8:105197
-
Travers MT, Barber MC, Tonner E, Quarrie L, Wilde CJ, Flint
DJ 1996 The role of prolactin and growth hormone in the regulation of
casein gene expression and mammary cell survival: relationships to milk
synthesis and secretion. Endocrinology 137:15301539[Abstract]
-
Mitra I 1974 Mammotrophic effect of prolactin enhanced by
thyroidectomy. Nature 248:525526[Medline]
-
Mitra I 1975 Potency of thyroid hormone analogues in
suppressing prolactin-mediated mammary growth in thyroidectomized rats.
Experientia 31:12181219[Medline]
-
Schmidt GH, Moger WH 1967 Effects of thyroactive materials
upon mammary gland growth, lactogenesis and lactation. Endocrinology 81:1418[Medline]
-
Meites J, Kragt CL 1964 Effects of a pituitary homotransplant
and thyroxin on body and mammary growth in immature hypophysectomized
rats. Endocrinology 75:565569[Medline]
-
Rosato RR, Gimenez MS, Jahn GA 1992 Effects of chronic thyroid
hormone administration on pregnancy, lactogenesis and lactation in the
rat. Acta Endocrinol (Copenh) 127:547554[Medline]
-
Rosato RR, Jammes H, Jahn GA 1998 Effects of chronic thyroxin
treatment on pregnancy in rats: effects on estrogen, progesterone,
prolactin and GH receptors in uterus, liver and mammary gland. Endocr
Res 24:269284[Medline]
-
Lu MH, Anderson RR 1998 Triiodothyronine-induced
hyper-thyroidism and reproduction in female rats. Endocr Res 22:237260
-
Tata JR, Kawahara A, Baker BS 1991 Prolactin inhibits both
thyroid hormone-induced morphogenesis and cell death in cultured
amphibian larval tissues. Dev Biol 146:7280[Medline]
-
Cabello G, Wrutniak C 1989 Thyroid hormones and growth:
relationships with growth hormone effects and regulation. Reprod Nutr
Dev 29:387402[Medline]
-
Lazar MA 1991 Steroid and thyroid hormone receptors.
Endocrinol Metab Clin North Am 20:681695[Medline]
-
Polk DH 1995 Thyroid hormone metabolism during development.
Reprod Fertil Dev 7:469477[Medline]
-
Lazar MA 1993 Thyroid hormone receptors: multiple forms,
multiple possibilities. Endocr Rev 14:184193[Medline]
-
Spindler BJ, MacLeod KM, Ring J, Baxter JD 1975 Thyroid
hormone receptors. Binding characteristics and lack of hormonal
dependency for nuclear localization. J Biol Chem 250:41134119[Abstract]
-
Lezoualch F, Hassan AH, Giraud P, Loefler JP, Lee SL, Demeneix
BA 1992 Assignment of the beta-thyroid hormone receptor to
3,5,3'-triiodothyronine-dependent inhibition of transcription from the
thyrotropin-releasing hormone promoter in chick hypothalamic neurons.
Mol Endocrinol 6:17971804[Abstract]
-
Guissouma A, Ghorbel MT, Seugnet I, Ouatas T, Demeneix BA 1998 Physiological regulation of hypothalamic TRH transcription in
vivo is T3 receptor isoform specific. FASEB
J 12:175564[Abstract/Free Full Text]
-
Sandhofer C, Schwartz HL, Mariash CN, Forrest D, Oppenheimer
JH 1998 ß- Receptor isoforms are not essential for thyroid
hormone-dependent acceleration of PCP-2 and myelin basic protein gene
expression in the developing brains of neonatal mice. Mol Cell
Endocrinol 137:109115[CrossRef][Medline]
-
Gauthier K, Chassande O, Plateroti M, Roux JP, Legrand C, Pain
B, Rousset B, Weiss R, Trouillas J, Samarut J 1999 Different functions
for the thyroid hormone receptors TR
and TRß in the control of
thyroid hormone production and post-natal development. EMBO J 18:623631[Abstract/Free Full Text]
-
Plateroti M, Chassande O, Fraichard A, Gauthier K, Freund JN,
Samarut J, Kedinger M 1999 Involvement of TR
- and ß-receptor
subtypes in mediation of T3 functions during
postnatal murine intestinal development. Gastroenterology 166:13671378
-
Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G
Umesomo K, Blumberg B, Kastner P, Mark M, Chambon P, Evans RM 1995 The
nuclear receptor superfamily: the second decade. Cell 83:835839[Medline]
-
Stoeklin E, Wissler M, Shaatzle D, Pfitzner E, Groner B 1999 Interactions in the transcriptional regulation exerted by Stat5a and by
members of steroid hormone receptor family. J Steroid Biochem Mol Biol 69:195204[CrossRef][Medline]
-
Stoeklin E, Wissler M, Gouilleux F, Groner B 1996 Functional
interactions between Stat5a and the glucocorticoid receptor. Nature 383:726728[CrossRef][Medline]
-
Wyszomierski SL, Yeh J, Rosen JM 1999 Glucocorticoid
receptor/signal transducer and activator of transcription (Stat5a)
interactions enhance Stat5a activation by prolonging Stat5a DNA binding
and tyrosine phosphorylation. Mol Endocrinol 13:330343[Abstract/Free Full Text]
-
Richter JK, Lange CA, Manning NG, Owen G, Powell R, Horwitz KB 1998 Convergence of progesterone with growth factor and cytokine
signaling in breast cancer. Progesterone receptors regulate signal
transducers and activators of transcription expression and activity.
J Biol Chem 273:3131731326[Abstract/Free Full Text]
-
Zhou YC, Waxman DJ 1999 Cross talk between Janus kinase-signal
transducer and activator of transcription (Jak-Stat) and peroxisome
proliferator-activated receptor-
(PPAR
) signaling pathways.
J Biol Chem 274:26722681[Abstract/Free Full Text]
-
Cella N, Groner B, Hynes NE 1998 Characterization of Stat5a
and Stat5b homodimers and heterodimers and their association with the
glucocorticoid receptor in mammary cells. Mol Cell Biol 18:17831792[Abstract/Free Full Text]
-
Lacasse EC, Lochnan AH, Walker P, Lefebvre YA 1993 Identification of binding proteins for nuclear localization signals of
the glucocorticoid and thyroid hormone receptors. Endocrinology 132:10171025[Abstract]
-
Paine PL, Feldherr CM 1972 Nucleocytoplasmic exchange of
macromolecule. Exp Cell Res 74:8198[Medline]
-
Paine PL, Moore LC, Horowitz SB 1975 Nuclear envelops
permeability. Nature 254:109114[Medline]
-
Leonard WJ, OShea JJ 1998 JAKS and STATS: biological
implications. Annu Rev Immunol 16:293322[CrossRef][Medline]
-
Pezet A, Ferrag F, Kelly PA, Edery M 1997 Tyrosine docking
sites of the rat prolactin receptor required for association and
activation of Stat5a. J Biol Chem 272:2504325050[Abstract/Free Full Text]
-
Zhu XG, Hanover JA, Hager GL, Cheng SY 1998 Hormone-induced
translocation of thyroid hormone receptors in living cells visualized
using a receptor green fluorescent protein chimera. J Biol Chem 273:2705827063[Abstract/Free Full Text]
-
Groner B, Gouilleux F 1995 Prolactin-mediated gene activation
in mammary epithelial cells. Curr Opinion Genet Dev 5:587594[CrossRef][Medline]
-
Johnson AM, Torres BA, Green MM, Szente BE, Siler KI, Larkin
III J, Subramanian PS 1998 Hypothesis: ligand/receptor-assisted nuclear
translocation of Stats. Proc Soc Exp Biol Med 218:149155[Abstract]
-
Li M, Boyages SC 1997 Expression of ß2-thyroid hormone
receptor in euthyroid and hypothyroid rat pituitary gland; an in
situ hybridization and immunocytochemal study. Brain Res 773:125131[CrossRef][Medline]
-
Leclerc P, Jibard N, Meng X, Schweizer-Groyer G, Fortin D,
Rajkowski K, Kang K, Catelli M-G, Beaulieu EE, Cadepond F 1998 Quantification of nucleoplasmic distribution of wild type and modified
proteins using confocal microscopy: interaction between 90-kDa heat
shock protein (HsP90
) and glucocorticosteroid receptor (GR).
Exp Cell Res 242:255264[CrossRef][Medline]
-
Pfitzner E, Jahne R, Wissler M, Stoeklin E, Groner B 1998 p300/CREB-binding protein enhances the prolactin-mediated
transcriptional induction through direct interaction with the
transactivation domain of Stat5a, but does not participate in the
Stat5a-mediated suppression of the glucocorticoid response.
Mol Endocrinol 12:15821593[Abstract/Free Full Text]
-
Moriggl R, Berchtold S, Freidrich K, Standke GJ, Kammer W,
Heim M, Wissler M, Stoecklin E, Gouilleux F, Groner B 1997 Comparison
of the transactivation domains of Stat5a and Stat6 in lymphoid cells
and mammary epithelial cells. Mol Cell Biol 17:36633678[Abstract]
-
Nelson CC, Hendy SC, Shukin RJ, Cheng H, Bruchovsky N,
Koop BF, Rennie PS 1999 Determinant of DNA sequence specificity of the
androgen, progesterone, and glucocorticoid receptor: evidence for
differential steroid receptor response elements. Mol Endocrinol 13:209020107[Abstract/Free Full Text]
-
Zhu YS, Yen PM, Chin WW, Pfaff DW 1996 Estrogen and thyroid
hormone interaction on regulation of gene expression. Proc Natl Acad
Sci USA 22:1258712592[CrossRef]
-
Welte T, Phillipp S, Tomasi JK, Bruno P, Caims C, Guftasson
JA, Doppler W 1993 Glucocorticoid receptor binding sites in the
promoter region of the milk protein genes. J Steroid Biochem Mol Biol 47:7581[CrossRef][Medline]
-
Zhou Y-C, Waxman DJ 1999 Stat5b down-regulates peroxisomes
proliferator-activated receptor a transcription by inhibition of
ligand-independent activation function region-1 trans-activation
domain. J Biol Chem 274:2987429882[Abstract/Free Full Text]
-
McKenna NJ, Lanz RB, OMalley BW 1999 Nuclear receptor
coregulators: cellular and molecular biology. Endocr Rev 20:321344[Abstract/Free Full Text]
-
Zhu M, John S, Berg M, Leonard WJ 1999 Functional association
of Nmi with Stat5a and Stat1 in IL-2 and IFN
-mediated signaling.
Cell 96:121130[Medline]
-
Sasaki S, Lesoon-Wood A, Dey A, Kuwata T, Weintraub BD,
Humphrey G, Yang W-M, Seto E, Yen PM, Howard B, Ozato K 1999 Ligand-induced recruitment of a histone deacetylase in the
negative-feedback regulation of the thyrotropin ß gene. EMBO J 18:53895398[Abstract/Free Full Text]
-
Lee SL, Stewart K, Goodman RH 1988 Structure of the gene
encoding rat thyrotropin releasing hormone. J Biol Chem 263:1660416609[Abstract/Free Full Text]
-
Goffin V, Kinet S, Ferrag F, Binart N, Martial JA, Kelly PA 1996 antagonist properties of human prolactin analogs that show
paradoxical agonistic activity in Nb2 bioassay. J Biol Chem 271:1657316579[Abstract/Free Full Text]
-
Lochnan HA, Buteau H, Richard S, Edery M, Kelly PA 1995 Functional activity of the human prolactin receptor and its ligands.
Mol Cell Endocrinol 114:9199[CrossRef][Medline]
-
Martini JF, Pezet A, Guezennec CY, Edery M, Postel-Vinay MC,
Kelly PA 1997 Monkey growth hormone (GH) receptor gene expression.
Evidence for two mechanisms for the generation of the GH binding
protein. J Biol Chem 272:1895118958[Abstract/Free Full Text]
-
Herrington J, Rui L, Luo G, Yu-Lee LY, Carter-Su C 1999 A
functional DNA binding domain is required for growth hormone-induced
nuclear accumulation of Stat5b. J Biol Chem 274:51385145[Abstract/Free Full Text]
-
Sakurai A, Nakai A, DeGroot LJ 1989 Expression of three forms
of thyroid hormone receptor in human tissues. Mol Endocrinol 3:392399[Abstract]
-
Bradford MM 1976 A rapid and sensitive method for the
quantification of microgram quantities of protein utilizing the
principle of protein-dye binding. Anal Biochem 72:248254[CrossRef][Medline]
-
Chen C, Okayama H 1987 High-efficiency transformation of
mammalian cells by plasmid DNA. Mol Cell Biol 7:27452752[Medline]